H3K4 Methyltransferase Smyd3 Mediates Vascular Smooth Muscle Cell Proliferation, Migration, and Neointima Formation.

Arterioscler Thromb Vasc Biol

State Key Laboratory of Quality Research in Chinese Medicine and School of Pharmacy, Macau University of Science and Technology, Macau, China (D.Y., Y.Z.Z.).

Published: June 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

[Figure: see text].

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.121.314689DOI Listing

Publication Analysis

Top Keywords

h3k4 methyltransferase
4
methyltransferase smyd3
4
smyd3 mediates
4
mediates vascular
4
vascular smooth
4
smooth muscle
4
muscle cell
4
cell proliferation
4
proliferation migration
4
migration neointima
4

Similar Publications

Canonical and Non-Canonical Functions of Histone H3K4 Methylation Modifiers in Cancer.

Cancer Sci

September 2025

Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Histone H3K4 modifications are altered in the regulation of gene expression and in multiple cellular processes during cancer development and progression. Understanding the roles of H3K4-modifying enzymes will provide novel insights into therapeutic tools for cancer treatment. H3K4-modifying enzymes catalyze the addition or removal of covalent modifications with specific substrate preferences.

View Article and Find Full Text PDF

Human opsin restoration by histone methylation using methyltransferase fusion protein SETD7-dCas9.

Mol Ther Nucleic Acids

September 2025

Department of Genetics and Biotechnology, College of Life Sciences, Kyung Hee University, Yongin-si, Gyeonggi-do 17104, Republic of Korea.

Epigenetic modulation enables precise gene regulation without altering DNA sequences. While histone acetylation has been widely utilized for gene activation, the therapeutic potential of histone methylation remains underexplored. In this study, we developed a new epigenetic activator by fusing the histone methyltransferase SETD7 to deactivated Cas9 (dCas9).

View Article and Find Full Text PDF

SET7/9 exhibits sigmoidal kinetics on nucleosomes, hyperbolic kinetics on histones by an ordered sequential mechanism and methylates lysine and arginine.

J Biol Chem

August 2025

Pharmaceutical analysis Laboratory, College of Pharmacy, University of Manitoba, 750 McDermot Avenue West, Winnipeg, Manitoba, R3E 0T5, Canada; Paul Albrechtsen Research Institute, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada. Electronic address:

SET7/9 (SETD7) is a SET domain protein lysine methyltransferase (PKMT). We characterized its activity using a mass spectrometry (MS) assay showing that it follows an ordered sequential enzyme kinetic mechanism where SAM is the first substrate to bind followed by histone H3, and mono-methylated histone H3 is the first product to dissociate, followed by SAH. Full-length histones H2A, H2B and H4 are also substrates for SET7/9.

View Article and Find Full Text PDF

The Complex Proteins Associated with Set1 (COMPASS)-like complex regulates developmental gene expression via histone 3 lysine 4 (H3K4) methylation and other transcriptional mechanisms. Several members of the lysine methyltransferase 2C and D (KMT2C/D)-COMPASS-like complex are implicated in human congenital heart and vascular defects. The investigation of the orthologous Trithorax-related (Trr)-COMPASS-like complex in (the fruit fly) offers a versatile model to explore gene function in the developing heart.

View Article and Find Full Text PDF

Rhizoctonia solani is a soil-borne pathogen causing destructive diseases on various economically important crops. Beneficial plant and fungus interactions are well acknowledged to enhance plant resistance to biotic stresses. However, the underlying mechanisms are not fully understood, especially the contribution of fungal epigenetic regulation remains poorly understood.

View Article and Find Full Text PDF